flecainide has been researched along with Cirrhosis in 5 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fibrosis was triggered by transforming growth factor β (TGF-β) pathway activation." | 1.46 | Transforming growth factor β receptor inhibition prevents ventricular fibrosis in a mouse model of progressive cardiac conduction disease. ( Baró, I; Cerpa, CO; Charpentier, F; Colledge, WH; Derangeon, M; Girardeau, A; Grace, AA; Huang, CLH; Jagu, B; Montnach, J; Patin, J; Toumaniantz, G, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hesselkilde, EZ | 1 |
| Carstensen, H | 1 |
| Flethøj, M | 1 |
| Fenner, M | 1 |
| Kruse, DD | 1 |
| Sattler, SM | 1 |
| Tfelt-Hansen, J | 1 |
| Pehrson, S | 1 |
| Braunstein, TH | 1 |
| Carlson, J | 1 |
| Platonov, PG | 1 |
| Jespersen, T | 1 |
| Buhl, R | 1 |
| Bai, J | 1 |
| Lo, A | 1 |
| Gladding, PA | 1 |
| Stiles, MK | 1 |
| Fedorov, VV | 1 |
| Zhao, J | 1 |
| Derangeon, M | 1 |
| Montnach, J | 1 |
| Cerpa, CO | 1 |
| Jagu, B | 1 |
| Patin, J | 1 |
| Toumaniantz, G | 1 |
| Girardeau, A | 1 |
| Huang, CLH | 1 |
| Colledge, WH | 1 |
| Grace, AA | 1 |
| Baró, I | 1 |
| Charpentier, F | 1 |
| Blana, A | 1 |
| Kaese, S | 1 |
| Fortmüller, L | 1 |
| Laakmann, S | 1 |
| Damke, D | 1 |
| van Bragt, K | 1 |
| Eckstein, J | 1 |
| Piccini, I | 1 |
| Kirchhefer, U | 1 |
| Nattel, S | 1 |
| Breithardt, G | 1 |
| Carmeliet, P | 1 |
| Carmeliet, E | 1 |
| Schotten, U | 1 |
| Verheule, S | 1 |
| Kirchhof, P | 1 |
| Fabritz, L | 1 |
| Blakeman, BP | 1 |
| Wilber, D | 1 |
5 other studies available for flecainide and Cirrhosis
| Article | Year |
|---|---|
Longitudinal study of electrical, functional and structural remodelling in an equine model of atrial fibrillation.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function, Left; Atri | 2019 |
In silico investigation of the mechanisms underlying atrial fibrillation due to impaired Pitx2.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Remodeling; Calcium; | 2020 |
Transforming growth factor β receptor inhibition prevents ventricular fibrosis in a mouse model of progressive cardiac conduction disease.
Topics: Age Factors; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzamides; Cardiomyopathies; Co | 2017 |
Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Echocardiography, Doppler; | 2010 |
Surgical ablation for idiopathic ventricular tachycardia.
Topics: Adult; Bundle-Branch Block; Cryosurgery; Fibrosis; Flecainide; Humans; Hypertrophy; Male; Papillary | 1990 |